Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-target Effects with Reduced Off-tumor Toxicity for Use in Immuno-Oncology

Clin Cancer Res; Autio, KA., Boni, V., Humphrey, RW. and Naing, A., October 2019.